Our laboratory has previously shown that treatment with function-blocking antibodies against the neurite growth-inhibitory protein Nogo-A (anti-Nogo-A immunotherapy) improves spatial memory performance after stroke in aged rats (Gillani et al., 2010), but a cellular mechanism of efficacy has not yet been identified. Here, RTN4 is linked to Stroke.